These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 25934414)
41. An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris. Arnold DF; Burton J; Shine B; Wojnarowska F; Misbah SA Br J Dermatol; 2009 May; 160(5):1098-102. PubMed ID: 19222460 [TBL] [Abstract][Full Text] [Related]
42. Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes. Kardos M; Levine D; Gürcan HM; Ahmed RA Obstet Gynecol Surv; 2009 Nov; 64(11):739-49. PubMed ID: 19849866 [TBL] [Abstract][Full Text] [Related]
44. Is it time to re-evaluate the treatment of pemphigus? Leventhal JS; Sanchez MR J Drugs Dermatol; 2012 Oct; 11(10):1200-6. PubMed ID: 23134985 [TBL] [Abstract][Full Text] [Related]
46. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide]. España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875 [TBL] [Abstract][Full Text] [Related]
47. Clinical efficacy of rituximab in the treatment of pemphigus: A retrospective study. Sharma VK; Bhari N; Gupta S; Sahni K; Khanna N; Ramam M; Sethuraman G Indian J Dermatol Venereol Leprol; 2016; 82(4):389-94. PubMed ID: 27279296 [TBL] [Abstract][Full Text] [Related]
48. Beneficial effects and safety of corticosteroids combined with traditional chinese medicine for pemphigus: a systematic review. Zhou T; Zhou P; Hua H; Liu X Evid Based Complement Alternat Med; 2015; 2015():815358. PubMed ID: 25793005 [TBL] [Abstract][Full Text] [Related]
51. Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus. Doukaki S; Platamone A; Alaimo R; Bongiorno MR J Dermatolog Treat; 2015 Feb; 26(1):67-72. PubMed ID: 24521072 [TBL] [Abstract][Full Text] [Related]
52. Pemphigus vulgaris: a therapeutic option for disease control. da Silva AV; Valones MA; Guimaraes RP; de Castro JF; Carvalho Ade A Gen Dent; 2008; 56(7):700-3. PubMed ID: 19014030 [TBL] [Abstract][Full Text] [Related]
53. Assessment of the therapeutic benefit of oral prednisolone and common adjuvant therapy in stage II of randomized controlled trial study for management of pemphigus vulgaris. Esmaili N; Chams-Davatchi C; Valikhani M; Daneshpazhooh M; Toosi S; Karimi A; Mortazavi H Arch Iran Med; 2014 Sep; 17(9):626-8. PubMed ID: 25204479 [TBL] [Abstract][Full Text] [Related]
54. Pemphigus vulgaris: a case-based update. Ben Lagha N; Poulesquen V; Roujeau JC; Alantar A; Maman L J Can Dent Assoc; 2005 Oct; 71(9):667-72. PubMed ID: 16271165 [TBL] [Abstract][Full Text] [Related]
55. Successful treatment with mycophenolate mofetil of four Japanese patients with pemphigus vulgaris. Koga H; Ishii N; Hamada T; Karashima T; Nakama T; Yasumoto S; Hashimoto T Eur J Dermatol; 2010; 20(4):472-5. PubMed ID: 20406724 [TBL] [Abstract][Full Text] [Related]